loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 40039 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Taro Pharmaceutical Industries

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Inke S.A: APIs manufacturing plant.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 TARO (1)

    filter

    01 CREAM;TOPICAL (1)

    filter

    01 RX (1)

    filter

    01 TRIAMCINOLONE ACETONIDE (1)

    filter

    01 No (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    TRIAMCINOLONE ACETONIDE

    PDF Supplier PDF
    URL Supplier Web Content
    CREAM; TOPICAL
    0.1%
    1997-11-26
    40039
    TRIAMCINOLONE ACET...
    RX
    No
    AT
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for FDA Orange Book APPLICATION 40039

    Looking for FDA Orange Book APPLICATION 40039 1

    19

    Taro Pharmaceutical Industries, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is TRIAMCINOLONE ACETONIDE, with a corresponding application number 40039.

    Regulatory Information RX

    With a dosage strength 0.1%

    Dosage Form Route CREAM; TOPICAL

    Reference Listed Drug No

    Approved since 1997-11-26

    Therapeutic Equivalence (TE) Code AT

    Post Enquiry
    POST ENQUIRY